Featured Blog Posts
Metagenomics
Clinical metagenomics and antibiotic resistance: the two bets every prescription makes
What makes clinical metagenomics different from traditional diagnostics and why has it taken almost 2 decades NGS to be used in this way?
Read More
Viral Bioprocessing
Why Gene Therapy Is So Expensive: Reducing Viral Vector Costs
Viral vector manufacturing costs are limiting gene therapy access. Explore how downstream processing and nuclease strategy can reduce COGS by up to 40%.
Read More
Viral Bioprocessing
What ACIB Sees in their Research, OXB Sees in Viral Vector Manufacturing [VIDEO]
Insights from OXB, a leading global CDMO, paired with new ACIB findings connecting hidden chromatin analytics to real-world downstream performance in viral vector manufacturing.
Read More
Viral Bioprocessing
Why AAV Quality Matters: New Tools Reveal How the Brain Responds to Stroke
Learn why AAV quality, including purity and specificity, directly impacts experimental results and what it means for viral vector research.
Read MoreThank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Questions? We're here to help
